MGP Ingredients (MGPI) Financials

$29.60 -0.53 (-1.76%)

Closing price 05/30/2025 04:00 PM Eastern

Extended Trading

$29.40 -0.20 (-0.66%)

As of 05/30/2025 04:54 PM Eastern

Annual Income Statements for MGP Ingredients

This table shows MGP Ingredients' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Income / (Loss) Attributable to Common Shareholders	34	106	109
Consolidated Net Income / (Loss)	34	107	109
Net Income / (Loss) Continuing Operations	34	107	109
Total Pre-Tax Income	68	142	140
Total Operating Income	74	149	149
Total Gross Profit	286	305	253
Total Revenue	704	837	782
Operating Revenue	704	837	782
Total Cost of Revenue	417	532	529
Operating Cost of Revenue	417	532	529
Total Operating Expenses	212	156	104
Selling, General & Admin Expense	81	91	75
Marketing Expense	41	38	30
Impairment Charge	74	19	0.00
Other Special Charges / (Income)	16	7.10	0.00
Total Other Income / (Expense), net	-5.98	-6.87	-8.79
Interest & Investment Income	-8.44	-6.65	-5.45
Other Income / (Expense), net	2.46	-0.22	-3.34
Income Tax Expense	34	35	31
Net Income / (Loss) Attributable to Noncontrolling Interest	0.18	0.73	0.28
Basic Earnings per Share	$1.56	$4.82	$4.94
Weighted Average Basic Shares Outstanding	22.02M	22.06M	22.00M
Diluted Earnings per Share	$1.56	$4.80	$108,591,004.92
Weighted Average Diluted Shares Outstanding	22.02M	22.17M	22.05M
Weighted Average Basic & Diluted Shares Outstanding	21.27M	22.07M	22.00M
Cash Dividends to Common per Share	$0.48	$0.48	$0.48

This table shows MGP Ingredients' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	-41	24	32	20	31	13	32	31	23	24
Consolidated Net Income / (Loss)	-42	24	32	21	31	13	32	31	23	24
Net Income / (Loss) Continuing Operations	-42	24	32	21	31	13	32	31	23	24
Total Pre-Tax Income	-32	31	42	27	41	17	43	41	28	31
Total Operating Income	-30	33	43	29	43	20	44	42	30	34
Total Gross Profit	74	66	83	63	85	73	76	70	63	59
Total Revenue	181	161	191	171	215	212	209	201	191	201
Operating Revenue	181	161	191	171	215	212	209	201	191	201
Total Cost of Revenue	106	96	108	108	130	138	133	131	128	142
Operating Cost of Revenue	106	96	108	108	130	138	133	131	128	142
Total Operating Expenses	105	33	40	34	42	54	32	28	33	25
Selling, General & Admin Expense	20	17	23	21	26	22	24	21	23	18
Marketing Expense	11	9.65	12	8.68	12	9.51	8.64	7.73	11	7.28
Impairment Charge	74	0.00	0.02	0.12	1.06	18	0.00	0.00	-	0.00
Other Special Charges / (Income)	0.20	6.40	5.40	4.10	2.90	4.20	0.00	0.00	-	0.00
Total Other Income / (Expense), net	-1.50	-1.15	-1.26	-2.07	-2.24	-2.38	-1.38	-0.87	-1.94	-2.70
Interest & Investment Income	-2.04	-2.17	-2.21	-2.02	-2.02	-2.35	-1.28	-1.00	-0.96	-1.35
Other Income / (Expense), net	0.54	1.03	0.94	-0.05	-0.23	-0.03	-0.09	0.12	-0.98	-1.35
Income Tax Expense	10	7.55	10	6.26	9.78	4.37	11	9.66	5.26	7.53
Net Income / (Loss) Attributable to Noncontrolling Interest	-0.51	0.21	0.28	0.19	0.29	0.01	0.16	0.27	0.00	0.01
Basic Earnings per Share	($1.86)	$1.07	$1.43	$0.92	$1.39	$0.59	$1.44	$1.40	$1.03	$1.07
Weighted Average Basic Shares Outstanding	22.02M	22.07M	22.12M	22.14M	22.06M	22.07M	22.06M	22.04M	22.00M	22.01M
Diluted Earnings per Share	($1.86)	$1.07	$1.43	$0.92	$1.39	$0.58	$1.44	$1.39	$108,591,001.02	$1.06
Weighted Average Diluted Shares Outstanding	22.02M	22.07M	22.12M	22.14M	22.17M	22.38M	22.14M	22.07M	22.05M	22.23M
Weighted Average Basic & Diluted Shares Outstanding	21.27M	21.95M	21.99M	22.01M	22.07M	22.02M	22.02M	22.01M	22.00M	21.99M

This table details how cash moves in and out of MGP Ingredients' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Net Change in Cash & Equivalents	6.89	-30	26
Net Cash From Operating Activities	102	84	89
Net Cash From Continuing Operating Activities	102	84	89
Net Income / (Loss) Continuing Operations	34	107	109
Consolidated Net Income / (Loss)	34	107	109
Depreciation Expense	22	22	21
Non-Cash Adjustments To Reconcile Net Income	77	31	7.92
Changes in Operating Assets and Liabilities, net	-31	-77	-49
Net Cash From Investing Activities	-72	-159	-48
Net Cash From Continuing Investing Activities	-72	-159	-48
Purchase of Property, Plant & Equipment	-71	-55	-45
Acquisitions	0.00	-104	-2.81
Other Investing Activities, net	-0.38	-0.26	0.32
Net Cash From Financing Activities	-24	46	-15
Net Cash From Continuing Financing Activities	-24	46	-15
Repayment of Debt	-89	-48	-3.40
Repurchase of Common Equity	-49	-0.80	-0.72
Payment of Dividends	-11	-11	-11
Issuance of Debt	125	105	0.00
Other Net Changes in Cash	-0.03	-	-

This table details how cash moves in and out of MGP Ingredients' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	4.50	-0.24	1.51	1.11	-9.64	6.07	-9.77	-16	-2.79	13
Net Cash From Operating Activities	29	44	4.96	25	35	28	15	5.02	17	29
Net Cash From Continuing Operating Activities	28	44	4.97	25	35	28	15	5.02	17	29
Net Income / (Loss) Continuing Operations	-42	24	32	21	31	13	32	31	23	24
Consolidated Net Income / (Loss)	-42	24	32	21	31	13	32	31	23	24
Depreciation Expense	5.69	5.68	5.33	5.29	5.84	5.78	5.32	5.17	5.20	5.33
Non-Cash Adjustments To Reconcile Net Income	75	0.09	0.07	1.57	6.54	20	2.85	1.57	3.37	2.34
Changes in Operating Assets and Liabilities, net	-10	14	-32	-2.82	-8.25	-11	-25	-33	-14	-2.06
Net Cash From Investing Activities	-18	-19	-6.39	-27	-13	-11	-119	-17	-16	-12
Net Cash From Continuing Investing Activities	-18	-19	-6.39	-27	-13	-11	-119	-17	-16	-12
Purchase of Property, Plant & Equipment	-18	-19	-6.37	-27	-13	-12	-14	-16	-16	-11
Other Investing Activities, net	-0.10	-0.02	-0.02	-0.24	0.65	0.22	-0.43	-0.71	0.64	0.05
Net Cash From Financing Activities	-5.76	-25	2.95	3.77	-32	-11	94	-4.27	-3.46	-3.65
Net Cash From Continuing Financing Activities	-5.76	-25	2.95	3.77	-32	-11	94	-4.27	-3.46	-3.65
Repayment of Debt	-22	-40	-12	-17	-30	-8.60	-8.60	-0.80	-0.80	-0.99
Repurchase of Common Equity	-37	-2.50	-2.77	-6.96	-	-	-	-0.80	-0.00	-0.00
Payment of Dividends	-2.62	-2.67	-2.67	-2.67	-2.67	-2.67	-2.67	-2.67	-2.66	-2.66
Issuance of Debt	55	20	20	30	-	-	105	0.00	-	-

This table presents MGP Ingredients' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Total Assets	1,406	1,392	1,158
Total Current Assets	546	514	454
Cash & Equivalents	25	18	48
Accounts Receivable	148	144	109
Inventories, net	365	347	290
Prepaid Expenses	3.98	3.58	2.96
Current Deferred & Refundable Income Taxes	3.45	1.19	4.33
Plant, Property, & Equipment, net	317	262	236
Total Noncurrent Assets	543	616	468
Long-Term Investments	7.02	5.20	5.53
Goodwill	248	322	226
Intangible Assets	268	272	217
Other Noncurrent Operating Assets	20	17	20
Total Liabilities & Shareholders' Equity	1,406	1,392	1,158
Total Liabilities	573	543	413
Total Current Liabilities	92	114	105
Short-Term Debt	6.40	6.40	5.60
Accounts Payable	66	74	66
Accrued Expenses	14	32	29
Other Taxes Payable	5.36	2.25	4.63
Total Noncurrent Liabilities	481	429	307
Long-Term Debt	317	281	225
Noncurrent Deferred & Payable Income Tax Liabilities	63	63	67
Other Noncurrent Operating Liabilities	100	85	15
Commitments & Contingencies	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	833	849	746
Total Preferred & Common Equity	834	850	747
Preferred Stock	0.00	0.00	0.00
Total Common Equity	834	850	747
Common Stock	339	332	326
Retained Earnings	564	540	443
Treasury Stock	-68	-21	-22
Accumulated Other Comprehensive Income / (Loss)	-0.66	-0.40	-0.30
Noncontrolling Interest	-1.62	-1.43	-1.08

This table presents MGP Ingredients' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	1,441	1,434	1,390	1,366	1,395	1,184	1,132
Total Current Assets	532	546	507	504	521	475	441
Cash & Equivalents	21	21	19	28	22	32	51
Accounts Receivable	130	159	133	127	148	129	108
Inventories, net	372	359	349	342	344	309	275
Prepaid Expenses	4.69	4.80	5.48	4.60	5.18	6.54	5.83
Current Deferred & Refundable Income Taxes	3.96	3.01	0.00	2.19	2.32	0.00	1.01
Plant, Property, & Equipment, net	292	276	271	243	251	241	221
Plant, Property & Equipment, gross	533	512	503	466	475	461	431
Accumulated Depreciation	241	236	232	222	225	220	210
Total Noncurrent Assets	616	612	612	619	624	468	471
Long-Term Investments	6.64	5.81	4.90	5.34	4.96	5.27	6.14
Goodwill	322	322	322	322	326	226	226
Intangible Assets	269	270	271	273	271	216	217
Other Noncurrent Operating Assets	19	15	15	20	22	20	21
Total Liabilities & Shareholders' Equity	1,441	1,434	1,390	1,366	1,395	1,184	1,132
Total Liabilities	528	541	525	548	588	408	408
Total Current Liabilities	82	85	80	90	119	102	101
Short-Term Debt	6.40	6.40	6.40	6.40	6.40	6.40	4.80
Accounts Payable	54	56	50	54	85	67	65
Accrued Expenses	20	18	16	27	21	17	26
Other Taxes Payable	2.48	4.49	3.80	2.72	5.95	7.39	4.71
Total Noncurrent Liabilities	445	456	444	458	469	306	307
Long-Term Debt	284	303	294	310	319	223	226
Noncurrent Deferred & Payable Income Tax Liabilities	62	63	64	65	69	68	66
Other Noncurrent Operating Liabilities	100	90	86	83	81	15	15
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	913	893	866	818	807	776	724
Total Preferred & Common Equity	914	894	867	820	808	777	725
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	914	894	867	820	808	777	725
Common Stock	337	336	336	330	329	328	324
Retained Earnings	609	587	558	511	501	471	423
Treasury Stock	-31	-29	-27	-21	-21	-22	-22
Accumulated Other Comprehensive Income / (Loss)	-0.02	-0.55	-0.44	-0.48	-0.17	-0.24	-0.86
Noncontrolling Interest	-1.59	-1.54	-1.48	-1.40	-1.28	-1.12	-0.93

This table displays calculated financial ratios and metrics derived from MGP Ingredients' official financial filings.

Metric	2024	2023	2022
Period end date	12/31/2024	12/31/2023	12/31/2022
Growth Metrics	-	-	-
Revenue Growth	-15.89%	6.92%	24.83%
EBITDA Growth	-42.01%	2.05%	15.85%
EBIT Growth	-48.19%	1.90%	16.37%
NOPAT Growth	-66.63%	-2.92%	22.09%
Net Income Growth	-67.83%	-1.60%	19.88%
EPS Growth	-67.50%	-100.00%	19.86%
Operating Cash Flow Growth	22.07%	-5.79%	0.76%
Free Cash Flow Firm Growth	133.94%	-275.75%	109.31%
Invested Capital Growth	0.99%	20.61%	8.39%
Revenue Q/Q Growth	-4.62%	2.94%	3.18%
EBITDA Q/Q Growth	-42.44%	9.47%	-8.77%
EBIT Q/Q Growth	-48.62%	10.51%	-9.81%
NOPAT Q/Q Growth	-66.72%	8.39%	-7.28%
Net Income Q/Q Growth	-67.94%	8.66%	6.12%
EPS Q/Q Growth	-67.57%	-100.00%	131.49%
Operating Cash Flow Q/Q Growth	-5.90%	28.33%	-0.89%
Free Cash Flow Firm Q/Q Growth	-31.69%	21.96%	-34.65%
Invested Capital Q/Q Growth	-4.39%	1.02%	2.72%
Profitability Metrics	-	-	-
Gross Margin	40.69%	36.43%	32.38%
EBITDA Margin	14.05%	20.38%	21.36%
Operating Margin	10.58%	17.77%	19.04%
EBIT Margin	10.93%	17.74%	18.61%
Profit (Net Income) Margin	4.90%	12.81%	13.92%
Tax Burden Percent	50.36%	75.58%	77.67%
Interest Burden Percent	89.02%	95.52%	96.26%
Effective Tax Rate	49.64%	24.42%	22.33%
Return on Invested Capital (ROIC)	3.35%	11.04%	13.05%
ROIC Less NNEP Spread (ROIC-NNEP)	2.27%	8.68%	9.49%
Return on Net Nonoperating Assets (RNNOA)	0.75%	2.40%	2.62%
Return on Equity (ROE)	4.10%	13.44%	15.67%
Cash Return on Invested Capital (CROIC)	2.36%	-7.65%	4.99%
Operating Return on Assets (OROA)	5.50%	11.64%	13.24%
Return on Assets (ROA)	2.46%	8.40%	9.90%
Return on Common Equity (ROCE)	4.11%	13.46%	15.68%
Return on Equity Simple (ROE_SIMPLE)	4.13%	12.60%	14.58%
Net Operating Profit after Tax (NOPAT)	37	112	116
NOPAT Margin	5.33%	13.43%	14.79%
Net Nonoperating Expense Percent (NNEP)	1.09%	2.36%	3.56%
Return On Investment Capital (ROIC_SIMPLE)	3.24%	9.88%	11.85%
Cost of Revenue to Revenue	59.31%	63.57%	67.62%
SG&A Expenses to Revenue	11.57%	10.93%	9.54%
R&D to Revenue	0.00%	0.00%	0.00%
Operating Expenses to Revenue	30.11%	18.66%	13.34%
Earnings before Interest and Taxes (EBIT)	77	148	146
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	99	171	167
Valuation Ratios	-	-	-
Price to Book Value (P/BV)	1.04	2.53	3.10
Price to Tangible Book Value (P/TBV)	2.72	8.38	7.62
Price to Revenue (P/Rev)	1.23	2.58	2.96
Price to Earnings (P/E)	25.21	20.25	21.30
Dividend Yield	1.22%	0.49%	0.46%
Earnings Yield	3.97%	4.94%	4.69%
Enterprise Value to Invested Capital (EV/IC)	1.03	2.17	2.70
Enterprise Value to Revenue (EV/Rev)	1.64	2.89	3.18
Enterprise Value to EBITDA (EV/EBITDA)	11.67	14.17	14.90
Enterprise Value to EBIT (EV/EBIT)	15.01	16.29	17.09
Enterprise Value to NOPAT (EV/NOPAT)	30.79	21.52	21.51
Enterprise Value to Operating Cash Flow (EV/OCF)	11.28	28.85	27.99
Enterprise Value to Free Cash Flow (EV/FCFF)	43.67	0.00	56.19
Leverage & Solvency	-	-	-
Debt to Equity	0.39	0.34	0.31
Long-Term Debt to Equity	0.38	0.33	0.30
Financial Leverage	0.33	0.28	0.28
Leverage Ratio	1.66	1.60	1.58
Compound Leverage Factor	1.48	1.53	1.52
Debt to Total Capital	27.99%	25.28%	23.60%
Short-Term Debt to Total Capital	0.55%	0.56%	0.57%
Long-Term Debt to Total Capital	27.43%	24.72%	23.03%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	-0.14%	-0.13%	-0.11%
Common Equity to Total Capital	72.15%	74.85%	76.51%
Debt to EBITDA	3.27	1.68	1.38
Net Debt to EBITDA	2.95	1.55	1.06
Long-Term Debt to EBITDA	3.21	1.65	1.35
Debt to NOPAT	8.63	2.56	1.99
Net Debt to NOPAT	7.77	2.35	1.53
Long-Term Debt to NOPAT	8.46	2.50	1.94
Altman Z-Score	2.53	4.22	5.35
Noncontrolling Interest Sharing Ratio	-0.18%	-0.16%	-0.11%
Liquidity Ratios	-	-	-
Current Ratio	5.91	4.51	4.31
Quick Ratio	1.88	1.43	1.49
Cash Flow Metrics	-	-	-
Free Cash Flow to Firm (FCFF)	26	-78	44
Operating Cash Flow to CapEx	143.69%	151.60%	196.23%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00
Efficiency Ratios	-	-	-
Asset Turnover	0.50	0.66	0.71
Accounts Receivable Turnover	4.81	6.60	7.75
Inventory Turnover	1.17	1.67	1.98
Fixed Asset Turnover	2.43	3.36	3.53
Accounts Payable Turnover	5.96	7.60	8.81
Days Sales Outstanding (DSO)	75.94	55.32	47.07
Days Inventory Outstanding (DIO)	311.29	218.45	184.78
Days Payable Outstanding (DPO)	61.20	48.05	41.44
Cash Conversion Cycle (CCC)	326.03	225.72	190.41
Capital & Investment Metrics	-	-	-
Invested Capital	1,124	1,113	923
Invested Capital Turnover	0.63	0.82	0.88
Increase / (Decrease) in Invested Capital	11	190	71
Enterprise Value (EV)	1,154	2,417	2,489
Market Capitalization	864	2,155	2,313
Book Value per Share	$38.00	$38.63	$33.95
Tangible Book Value per Share	$14.48	$11.68	$13.81
Total Capital	1,156	1,136	976
Total Debt	324	287	230
Total Long-Term Debt	317	281	225
Net Debt	291	264	177
Capital Expenditures (CapEx)	71	55	45
Debt-free, Cash-free Net Working Capital (DFCFNWC)	435	388	306
Debt-free Net Working Capital (DFNWC)	460	407	354
Net Working Capital (NWC)	454	400	349
Net Nonoperating Expense (NNE)	3.01	5.19	6.83
Net Nonoperating Obligations (NNO)	291	264	177
Total Depreciation and Amortization (D&A)	22	22	21
Debt-free, Cash-free Net Working Capital to Revenue	61.80%	46.41%	39.18%
Debt-free Net Working Capital to Revenue	65.39%	48.60%	45.30%
Net Working Capital to Revenue	64.48%	47.84%	44.58%
Earnings Adjustments	-	-	-
Adjusted Basic Earnings per Share	$1.56	$4.82	$0.00
Adjusted Weighted Average Basic Shares Outstanding	22.02M	22.06M	0.00
Adjusted Diluted Earnings per Share	$1.56	$4.80	$0.00
Adjusted Weighted Average Diluted Shares Outstanding	22.02M	22.17M	0.00
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	21.27M	22.07M	0.00
Normalized Net Operating Profit after Tax (NOPAT)	83	132	116
Normalized NOPAT Margin	11.77%	15.82%	14.79%
Pre Tax Income Margin	9.73%	16.94%	17.92%
Debt Service Ratios	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00
Payout Ratios	-	-	-
Dividend Payout Ratio	30.84%	9.96%	9.78%
Augmented Payout Ratio	172.36%	10.71%	10.44%

This table displays calculated financial ratios and metrics derived from MGP Ingredients' official financial filings.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-15.87%	-23.70%	-8.71%	-15.15%	12.51%	5.21%	7.19%	2.96%	14.47%	13.89%
EBITDA Growth	-149.73%	53.42%	0.59%	-27.10%	43.49%	-32.36%	24.84%	-15.97%	-32.12%	0.37%
EBIT Growth	-169.79%	69.53%	0.64%	-30.75%	49.12%	-39.05%	28.64%	-16.86%	-35.52%	0.15%
NOPAT Growth	-165.07%	66.33%	-0.05%	-30.05%	35.98%	-42.09%	20.49%	-17.80%	-27.42%	3.40%
Net Income Growth	-235.28%	82.32%	0.17%	-33.67%	37.91%	-44.61%	26.03%	-16.96%	38.69%	-0.19%
EPS Growth	-233.81%	84.48%	-0.69%	-33.81%	-100.00%	-45.28%	25.22%	-17.75%	131.49%	-100.00%
Operating Cash Flow Growth	-18.23%	54.42%	-67.23%	390.40%	110.86%	-2.69%	-27.20%	-77.41%	-4.55%	25.30%
Free Cash Flow Firm Growth	79.44%	73.89%	79.39%	-158.76%	-232.68%	-501.78%	-314.70%	89.26%	91.19%	94.09%
Invested Capital Growth	0.99%	6.71%	6.35%	17.90%	20.61%	22.65%	23.94%	10.26%	8.39%	6.78%
Revenue Q/Q Growth	11.98%	-15.38%	11.87%	-20.63%	1.54%	1.26%	3.98%	5.24%	-5.05%	3.16%
EBITDA Q/Q Growth	-161.66%	-20.92%	45.40%	-29.85%	90.22%	-48.15%	5.37%	38.08%	-10.34%	-4.31%
EBIT Q/Q Growth	-189.03%	-24.23%	53.58%	-32.63%	116.25%	-55.02%	5.68%	45.06%	-11.62%	-5.06%
NOPAT Q/Q Growth	-186.15%	-24.99%	48.73%	-32.30%	120.24%	-54.93%	4.08%	31.61%	-6.21%	-6.23%
Net Income Q/Q Growth	-276.00%	-25.47%	55.54%	-33.70%	137.21%	-59.05%	3.00%	37.85%	-4.73%	-6.84%
EPS Q/Q Growth	-273.83%	-25.17%	55.43%	-33.81%	139.66%	-59.72%	3.60%	-100.00%	10,244,433,958.49%	-7.83%
Operating Cash Flow Q/Q Growth	-34.52%	785.86%	-79.86%	-30.00%	23.65%	87.97%	201.43%	-69.90%	-42.93%	40.62%
Free Cash Flow Firm Q/Q Growth	34.24%	-32.30%	75.40%	3.93%	16.50%	-4.44%	-208.83%	-23.51%	-51.05%	28.03%
Invested Capital Q/Q Growth	-4.39%	0.00%	2.94%	2.63%	1.02%	-0.35%	14.12%	4.99%	2.72%	0.70%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	41.19%	40.76%	43.62%	36.82%	39.62%	34.71%	36.50%	34.74%	33.10%	29.36%
EBITDA Margin	-13.39%	24.32%	26.03%	20.02%	22.66%	12.10%	23.62%	23.31%	17.77%	18.81%
Operating Margin	-16.84%	20.17%	22.74%	16.95%	20.04%	9.37%	21.12%	20.68%	15.56%	16.84%
EBIT Margin	-16.54%	20.80%	23.23%	16.92%	19.94%	9.36%	21.08%	20.74%	15.04%	16.16%
Profit (Net Income) Margin	-23.23%	14.78%	16.78%	12.07%	14.45%	6.18%	15.29%	15.44%	11.79%	11.75%
Tax Burden Percent	131.47%	75.95%	76.00%	76.67%	76.04%	74.96%	74.74%	76.27%	81.05%	75.83%
Interest Burden Percent	106.83%	93.53%	95.03%	93.01%	95.29%	88.12%	97.09%	97.61%	96.66%	95.85%
Effective Tax Rate	0.00%	24.05%	24.00%	23.33%	23.96%	25.04%	25.26%	23.73%	18.95%	24.17%
Return on Invested Capital (ROIC)	-7.42%	9.93%	11.94%	9.93%	12.53%	5.71%	12.68%	13.46%	11.12%	11.13%
ROIC Less NNEP Spread (ROIC-NNEP)	-14.87%	9.61%	11.61%	9.25%	11.75%	4.93%	12.26%	13.12%	10.30%	10.11%
Return on Net Nonoperating Assets (RNNOA)	-4.91%	3.03%	3.97%	2.64%	3.25%	1.46%	3.95%	3.53%	2.85%	3.02%
Return on Equity (ROE)	-12.32%	12.96%	15.91%	12.57%	15.78%	7.17%	16.63%	16.99%	13.97%	14.15%
Cash Return on Invested Capital (CROIC)	2.36%	3.40%	2.86%	-6.69%	-7.65%	-9.98%	-9.92%	2.02%	4.99%	7.80%
Operating Return on Assets (OROA)	-8.32%	10.94%	12.94%	10.60%	13.08%	6.09%	13.52%	14.46%	10.70%	11.40%
Return on Assets (ROA)	-11.68%	7.77%	9.35%	7.56%	9.48%	4.02%	9.81%	10.76%	8.38%	8.29%
Return on Common Equity (ROCE)	-12.35%	12.98%	15.93%	12.59%	15.80%	7.19%	16.66%	17.01%	13.99%	14.17%
Return on Equity Simple (ROE_SIMPLE)	0.00%	11.76%	10.81%	11.15%	0.00%	12.03%	13.50%	13.19%	0.00%	14.15%
Net Operating Profit after Tax (NOPAT)	-21	25	33	22	33	15	33	32	24	26
NOPAT Margin	-11.79%	15.32%	17.28%	13.00%	15.24%	7.03%	15.79%	15.77%	12.61%	12.77%
Net Nonoperating Expense Percent (NNEP)	7.46%	0.32%	0.33%	0.68%	0.77%	0.78%	0.42%	0.34%	0.82%	1.02%
Return On Investment Capital (ROIC_SIMPLE)	-1.84%	-	-	-	2.88%	-	-	-	2.47%	-
Cost of Revenue to Revenue	58.81%	59.24%	56.38%	63.18%	60.38%	65.29%	63.50%	65.26%	66.90%	70.64%
SG&A Expenses to Revenue	11.31%	10.66%	11.93%	12.30%	12.00%	10.19%	11.25%	10.21%	11.85%	8.90%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	58.03%	20.59%	20.88%	19.86%	19.58%	25.33%	15.38%	14.06%	17.54%	12.52%
Earnings before Interest and Taxes (EBIT)	-30	34	44	29	43	20	44	42	29	33
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-24	39	50	34	49	26	49	47	34	38
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.04	2.00	1.83	2.18	2.53	2.82	2.87	2.72	3.10	3.19
Price to Tangible Book Value (P/TBV)	2.72	5.66	5.40	6.89	8.38	10.24	11.00	6.31	7.62	8.22
Price to Revenue (P/Rev)	1.23	2.48	2.08	2.35	2.58	2.84	2.90	2.68	2.96	3.05
Price to Earnings (P/E)	25.21	17.18	17.04	19.69	20.25	23.53	21.38	20.65	21.30	31.37
Dividend Yield	1.22%	0.58%	0.65%	0.56%	0.49%	0.46%	0.45%	0.50%	0.46%	0.46%
Earnings Yield	3.97%	5.82%	5.87%	5.08%	4.94%	4.25%	4.68%	4.84%	4.69%	3.19%
Enterprise Value to Invested Capital (EV/IC)	1.03	1.78	1.63	1.90	2.17	2.35	2.37	2.38	2.70	2.77
Enterprise Value to Revenue (EV/Rev)	1.64	2.84	2.43	2.69	2.89	3.19	3.27	2.92	3.18	3.28
Enterprise Value to EBITDA (EV/EBITDA)	11.67	12.18	12.12	13.72	14.17	16.64	15.60	14.56	14.90	13.57
Enterprise Value to EBIT (EV/EBIT)	15.01	13.98	14.11	15.97	16.29	19.30	17.83	16.79	17.09	15.39
Enterprise Value to NOPAT (EV/NOPAT)	30.79	18.57	18.65	21.07	21.52	25.01	22.91	21.16	21.51	19.91
Enterprise Value to Operating Cash Flow (EV/OCF)	11.28	19.24	20.56	20.95	28.85	39.69	39.67	32.11	27.99	27.69
Enterprise Value to Free Cash Flow (EV/FCFF)	43.67	54.07	58.79	0.00	0.00	0.00	0.00	123.27	56.19	36.66
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.39	0.32	0.35	0.35	0.34	0.39	0.40	0.30	0.31	0.32
Long-Term Debt to Equity	0.38	0.31	0.34	0.34	0.33	0.38	0.39	0.29	0.30	0.31
Financial Leverage	0.33	0.32	0.34	0.29	0.28	0.30	0.32	0.27	0.28	0.30
Leverage Ratio	1.66	1.62	1.66	1.57	1.60	1.62	1.66	1.55	1.58	1.61
Compound Leverage Factor	1.78	1.52	1.58	1.46	1.52	1.43	1.61	1.52	1.53	1.54
Debt to Total Capital	27.99%	24.11%	25.73%	25.79%	25.28%	27.90%	28.71%	22.83%	23.60%	24.20%
Short-Term Debt to Total Capital	0.55%	0.53%	0.53%	0.55%	0.56%	0.56%	0.57%	0.64%	0.57%	0.50%
Long-Term Debt to Total Capital	27.43%	23.57%	25.20%	25.24%	24.72%	27.34%	28.15%	22.20%	23.03%	23.69%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	-0.14%	-0.13%	-0.13%	-0.13%	-0.13%	-0.12%	-0.11%	-0.11%	-0.11%	-0.10%
Common Equity to Total Capital	72.15%	76.02%	74.39%	74.33%	74.85%	72.22%	71.40%	77.28%	76.51%	75.90%
Debt to EBITDA	3.27	1.69	1.96	1.91	1.68	2.03	1.94	1.45	1.38	1.26
Net Debt to EBITDA	2.95	1.53	1.79	1.75	1.55	1.82	1.78	1.22	1.06	0.95
Long-Term Debt to EBITDA	3.21	1.65	1.92	1.87	1.65	1.99	1.90	1.41	1.35	1.24
Debt to NOPAT	8.63	2.57	3.01	2.93	2.56	3.06	2.84	2.11	1.99	1.85
Net Debt to NOPAT	7.77	2.33	2.75	2.69	2.35	2.73	2.61	1.77	1.53	1.40
Long-Term Debt to NOPAT	8.46	2.52	2.95	2.86	2.50	2.99	2.79	2.05	1.94	1.81
Altman Z-Score	2.28	3.64	3.42	3.74	3.97	4.06	3.90	4.82	5.02	5.05
Noncontrolling Interest Sharing Ratio	-0.18%	-0.17%	-0.17%	-0.16%	-0.16%	-0.15%	-0.13%	-0.11%	-0.11%	-0.09%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.91	6.46	6.44	6.32	4.51	5.59	4.39	4.65	4.31	4.37
Quick Ratio	1.88	1.84	2.12	1.90	1.43	1.72	1.43	1.57	1.49	1.57
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-32	-49	-37	-151	-157	-189	-181	-58	-47	-31
Operating Cash Flow to CapEx	156.93%	225.83%	77.84%	91.11%	266.40%	236.94%	109.53%	30.92%	103.58%	262.66%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.50	0.53	0.56	0.63	0.66	0.65	0.64	0.70	0.71	0.71
Accounts Receivable Turnover	4.81	5.74	5.14	6.16	6.60	6.94	6.34	6.83	7.75	7.59
Inventory Turnover	1.17	1.23	1.38	1.55	1.67	1.72	1.73	1.89	1.98	2.00
Fixed Asset Turnover	2.43	2.76	2.99	3.15	3.36	3.50	3.47	3.52	3.53	3.63
Accounts Payable Turnover	5.96	8.15	6.86	8.74	7.60	8.89	7.34	8.98	8.81	10.12
Days Sales Outstanding (DSO)	75.94	63.61	71.02	59.23	55.32	52.63	57.55	53.41	47.07	48.09
Days Inventory Outstanding (DIO)	311.29	295.89	265.25	236.02	218.45	212.82	210.88	193.12	184.78	182.30
Days Payable Outstanding (DPO)	61.20	44.77	53.24	41.75	48.05	41.08	49.75	40.63	41.44	36.07
Cash Conversion Cycle (CCC)	326.03	314.73	283.03	253.50	225.72	224.37	218.69	205.91	190.41	194.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,124	1,175	1,175	1,142	1,113	1,101	1,105	969	923	898
Invested Capital Turnover	0.63	0.65	0.69	0.76	0.82	0.81	0.80	0.85	0.88	0.87
Increase / (Decrease) in Invested Capital	11	74	70	173	190	203	213	90	71	57
Enterprise Value (EV)	1,154	2,092	1,917	2,166	2,417	2,591	2,621	2,303	2,489	2,485
Market Capitalization	864	1,831	1,636	1,891	2,155	2,309	2,324	2,112	2,313	2,312
Book Value per Share	$38.00	$41.59	$40.63	$39.16	$38.63	$37.23	$36.73	$35.32	$33.95	$32.96
Tangible Book Value per Share	$14.48	$14.72	$13.76	$12.40	$11.68	$10.24	$9.60	$15.20	$13.81	$12.79
Total Capital	1,156	1,203	1,202	1,166	1,136	1,135	1,132	1,006	976	955
Total Debt	324	290	309	301	287	317	325	230	230	231
Total Long-Term Debt	317	284	303	294	281	310	319	223	225	226
Net Debt	291	263	283	276	264	283	298	193	177	174
Capital Expenditures (CapEx)	18	19	6.37	27	13	12	14	16	16	11
Debt-free, Cash-free Net Working Capital (DFCFNWC)	435	435	447	414	388	392	387	348	306	294
Debt-free Net Working Capital (DFNWC)	460	456	468	433	407	420	409	380	354	345
Net Working Capital (NWC)	454	450	462	427	400	414	402	373	349	340
Net Nonoperating Expense (NNE)	21	0.87	0.96	1.59	1.70	1.78	1.03	0.67	1.57	2.05
Net Nonoperating Obligations (NNO)	291	263	283	276	264	283	298	193	177	174
Total Depreciation and Amortization (D&A)	5.69	5.68	5.33	5.29	5.84	5.78	5.32	5.17	5.20	5.33
Debt-free, Cash-free Net Working Capital to Revenue	61.80%	59.01%	56.73%	51.31%	46.41%	48.26%	48.20%	44.13%	39.18%	38.77%
Debt-free Net Working Capital to Revenue	65.39%	61.82%	59.40%	53.72%	48.60%	51.71%	50.94%	48.15%	45.30%	45.46%
Net Working Capital to Revenue	64.48%	60.95%	58.59%	52.93%	47.84%	50.92%	50.14%	47.34%	44.58%	44.82%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.86)	$1.07	$1.43	$0.92	$1.39	$0.59	$1.44	$1.40	$1.03	$1.07
Adjusted Weighted Average Basic Shares Outstanding	22.02M	22.07M	22.12M	22.14M	22.06M	22.07M	22.06M	22.04M	22.00M	22.01M
Adjusted Diluted Earnings per Share	($1.86)	$1.07	$1.43	$0.92	$1.39	$0.58	$1.44	$1.39	$108,591,001.02	$23,620,001.06
Adjusted Weighted Average Diluted Shares Outstanding	22.02M	22.07M	22.12M	22.14M	22.17M	22.38M	22.14M	22.07M	22.05M	22.23M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	21.27M	21.95M	21.99M	22.01M	22.07M	22.02M	22.02M	22.01M	22.00M	21.99M
Normalized Net Operating Profit after Tax (NOPAT)	30	30	37	25	36	32	33	32	24	26
Normalized NOPAT Margin	16.85%	18.33%	19.44%	14.89%	16.64%	15.01%	15.79%	15.77%	12.61%	12.77%
Pre Tax Income Margin	-17.67%	19.46%	22.08%	15.74%	19.00%	8.25%	20.46%	20.24%	14.54%	15.49%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	30.84%	9.94%	11.04%	11.04%	9.96%	10.82%	9.77%	10.39%	9.78%	10.37%
Augmented Payout Ratio	172.36%	21.32%	21.11%	18.24%	10.71%	11.63%	10.50%	11.17%	10.44%	11.07%

Frequently Asked Questions About MGP Ingredients' Financials

When does MGP Ingredients's fiscal year end?

According to the most recent income statement we have on file, MGP Ingredients' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has MGP Ingredients' net income changed over the last 2 years?

MGP Ingredients' net income appears to be on a downward trend, with a most recent value of $34.47 million in 2024, falling from $108.87 million in 2022. The previous period was $107.13 million in 2023. Check out MGP Ingredients' forecast to explore projected trends and price targets.

What is MGP Ingredients's operating income?

MGP Ingredients's total operating income in 2024 was $74.43 million, based on the following breakdown:

Total Gross Profit: $286.32 million
Total Operating Expenses: $211.89 million

How has MGP Ingredients revenue changed over the last 2 years?

Over the last 2 years, MGP Ingredients' total revenue changed from $782.36 million in 2022 to $703.63 million in 2024, a change of -10.1%.

How much debt does MGP Ingredients have?

MGP Ingredients' total liabilities were at $573.24 million at the end of 2024, a 5.5% increase from 2023, and a 38.9% increase since 2022.

How much cash does MGP Ingredients have?

In the past 2 years, MGP Ingredients' cash and equivalents has ranged from $18.39 million in 2023 to $47.89 million in 2022, and is currently $25.27 million as of their latest financial filing in 2024.

How has MGP Ingredients' book value per share changed over the last 2 years?

Over the last 2 years, MGP Ingredients' book value per share changed from 33.95 in 2022 to 38.00 in 2024, a change of 11.9%.

Related Companies

This page (NASDAQ:MGPI) was last updated on 6/1/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

MGP Ingredients (MGPI) Financials

Frequently Asked Questions About MGP Ingredients' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

MGP Ingredients (MGPI) Financials

Annual Income Statements for MGP Ingredients

Quarterly Income Statements for MGP Ingredients

Annual Cash Flow Statements for MGP Ingredients

Quarterly Cash Flow Statements for MGP Ingredients

Annual Balance Sheets for MGP Ingredients

Quarterly Balance Sheets for MGP Ingredients

Annual Metrics And Ratios for MGP Ingredients

Quarterly Metrics And Ratios for MGP Ingredients

Frequently Asked Questions About MGP Ingredients' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools